Adverum Biotechnologies (ADVM) PT Lowered to $10 at RBC Capital
Tweet Send to a Friend
RBC Capital analyst Luca Issi lowered the price target on Adverum Biotechnologies (NASDAQ: ADVM) to $10.00 (from $12.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
